Quanta Therapeutics
PrivateLast Round
Series D
May 22, 2023
Total Funding Raised
$142.7M
Company Overview
Quanta Therapeutics is a biotechnology company focused on developing drugs aimed at treating RAS-driven cancers through the use of optical technology to discover small molecules that modulate RAS protein conformation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quanta Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Quanta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 22, 2023 | ||||
| Series C | Oct 26, 2021 |
Key People
Founding team and executive leadership
Quanta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series D, Series C |
| Avidity Partners Management | Series D |
| Vida Ventures | Series D, Series C, Series B |
| Avidity Partners | Series D |
| WS Investment Company | Series D |
| Logos Capital | Series C, Series B |
| AbbVie Ventures | Series D, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 24, 2025
Presenting first clinical data for drug candidate QTX3034 at AACR-NCI-EORTC conference.
- Oct 24, 2025
First clinical data for QTX3034 to be presented at AACR-NCI-EORTC Conference.
Quanta Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Quanta Therapeutics's valuation, stock price, and market status.
